In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 0.0 | 0.0 | 0.0 | |
| Total Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 0.0 | 0.0 | 0.0 | |
| Expenses | |||||||||||||
| + Finance Costs | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | |
| + Depreciation & Amortisation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Expenses | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | |
| EBIT | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.1 | -0.6 | -0.6 | -0.6 | |
| Pretax Income | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.1 | -0.6 | -0.6 | -0.6 | |
| Net Income | -0.9 | -0.9 | -0.9 | -1.1 | -0.9 | -0.9 | -0.9 | -1.0 | -0.2 | -0.9 | -0.8 | -0.9 | |
| + Net Income — Continuing Ops | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.1 | -0.6 | -0.6 | -0.6 | |
| + Net Income — Discontinued Ops | -0.2 | -0.2 | -0.2 | -0.3 | -0.1 | -0.1 | -0.2 | -0.3 | -0.2 | -0.3 | -0.2 | -0.3 | |
| + Other Comprehensive Income | -0.0 | 0.0 | -0.0 | 0.0 | 0.0 | -0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Comprehensive Income | -0.9 | -0.9 | -0.9 | -1.0 | -0.9 | -0.9 | -0.9 | -1.0 | -0.2 | -0.9 | -0.8 | -0.9 | |
| Per Share | |||||||||||||
| Basic EPS | -0.18 | -0.19 | -0.19 | -0.21 | -0.18 | -0.18 | -0.18 | -0.21 | -0.05 | -0.18 | -0.17 | -0.19 | |
| Diluted EPS | -0.18 | -0.19 | -0.19 | -0.21 | -0.18 | -0.18 | -0.18 | -0.21 | -0.05 | -0.18 | -0.17 | -0.19 | |
| Continuing & Discontinued Operations | |||||||||||||
| + Discontinued Operations — before Tax | -0.2 | -0.2 | -0.2 | -0.3 | -0.1 | -0.1 | -0.2 | -0.3 | -0.2 | -0.3 | -0.2 | -0.3 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Items NOT to be Reclassified to P&L | -0.0 | 0.0 | -0.0 | 0.0 | 0.0 | -0.0 | 0.0 | — | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | -0.14 | -0.14 | -0.14 | -0.14 | -0.15 | -0.15 | -0.14 | -0.15 | -0.01 | -0.13 | -0.13 | -0.13 | |
| Diluted EPS — Continuing Operations | -0.14 | -0.14 | -0.14 | -0.14 | -0.15 | -0.15 | -0.14 | -0.15 | -0.01 | -0.13 | -0.13 | -0.13 | |
| Basic EPS — Discontinued Operations | -0.04 | -0.05 | -0.05 | -0.07 | -0.03 | -0.03 | -0.04 | -0.06 | -0.04 | -0.05 | -0.04 | -0.06 | |
| Diluted EPS — Discontinued Operations | -0.04 | -0.05 | -0.05 | -0.07 | -0.03 | -0.03 | -0.04 | -0.06 | -0.04 | -0.05 | -0.04 | -0.06 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | 1.8 | — | 1.9 | — | 1.3 | — | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.7 | -0.1 | -0.6 | -0.6 | -0.6 | |
| Net Income Adj (tax-effected) | -0.9 | -0.9 | -0.9 | -1.1 | -0.9 | -0.9 | -0.9 | -1.0 | -0.2 | -0.9 | -0.8 | -0.9 | |
| EPS Adj | -0.18 | -0.19 | -0.19 | -0.21 | -0.18 | -0.18 | -0.18 | -0.21 | -0.05 | -0.18 | -0.17 | -0.19 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | 50.2 | 50.2 | 50.2 | 50.2 | 50.2 | 50.2 | 50.2 | 50.2 | 50.2 | 50.2 | 50.2 | 50.2 | |